Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.74M |
Day Range | - - - |
52 Wk Range | 2.01 - 7.45 |
Market Cap | $1.16B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 3.46% |
Days to Cover | 4.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Autolus Therapeutics (NASDAQ:AUTL) through any online brokerage.
Other companies in Autolus Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Immatics (NASDAQ:IMTX).
There is no analysis for Autolus Therapeutics.
Autolus Therapeutics has a consensus price target of $8.72.
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $4.35 last updated July 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Autolus Therapeutics.
Autolus Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Autolus Therapeutics.
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.